. 2023 Mar 31;14:1142581. doi: 10.3389/fphar.2023.1142581

TABLE 2.

Treatment schedule.

Experiment	Compound	Concentration (µM)	Vehicle	Vehicle concentration (%)	Treatment schedule	Sample points (days)	Study design
1	Olaparib	0, 1, 10	DMSO	0.01	14 days treatment	0, 14, 28	Independent measures
1	Olaparib	0, 1, 10	DMSO	0.01	14 days no drug	0, 14, 28	Independent measures
2	Olaparib	0, 1, 10	DMSO	0.01	14 days treatment	0, 7, 14, 21, 28	Repeated measures
2	Olaparib	0, 1, 10	DMSO	0.01	14 days no drug	0, 7, 14, 21, 28	Repeated measures
3	Carboplatin	0, 2.5, 5, 10, 25, 50	Media (SFEM II)	N/A	1 day treatment	0, 1, 4, 7, 8, 11, 14	Repeated measures
3	Carboplatin	0, 2.5, 5, 10, 25, 50	Media (SFEM II)	N/A	13 days no drug	0, 1, 4, 7, 8, 11, 14	Repeated measures